A blood test for Alzheimer's built on circular RNA

Researchers report a blood-based circular RNA signature that could flag Alzheimer's disease early, before symptoms appear.

A study in Nature Medicine describes an approach to detecting Alzheimer's disease using circular RNA measured from blood. The signal here is that a signature drawn from a blood sample could identify the disease early — potentially before symptoms become apparent.

If it holds up, a blood-based test matters for access. Current paths to an Alzheimer's diagnosis often lean on brain imaging or spinal fluid analysis, which are expensive, invasive, and unevenly available. A cheap blood draw could bring early detection within reach of far more people, and earlier detection is what makes emerging treatments and planning useful.

We are working only from the metadata line for this item. The study's methods, sample sizes, and accuracy figures — and how far this is from a test you could actually order — sit with the source. Blood-based detection remains an active research area, so treat this as a promising direction rather than a settled tool.

Source: Nature Medicine